Centiva Capital, LP Amgen Inc Call Options Transaction History

Centiva Capital, LP

$4.79 Billion
Q3 2024

Call Options

21 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $1.86 Million - $2.02 Million	6,000 Added 57.14%	16,500 $5.32 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $919,625 - $1.12 Million	3,500 Added 50.0%	10,500 $3.28 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $941,045 - $1.14 Million	-3,500 Reduced 33.33%	7,000 $1.99 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $9.15 Million - $10.3 Million	-35,800 Reduced 77.32%	10,500 $3.02 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $7.28 Million - $9.04 Million	33,300 Added 256.15%	46,300 $12.4 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $2.7 Million - $3.19 Million	-12,600 Reduced 49.22%	13,000 $2.89 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $3.61 Million - $4.4 Million	-16,000 Reduced 38.46%	25,600 $6.19 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $480,963 - $611,121	-2,100 Reduced 4.81%	41,600 $10.9 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $2.15 Million - $2.43 Million	9,600 Added 28.15%	43,700 $9.85 Million
Q2 2022 Aug 17, 2022	BUY	$230.71 - $256.74 $2.08 Million - $2.31 Million	9,000 Added 35.86%	34,100 $8.3 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $4.41 Million - $4.88 Million	20,100 Added 402.0%	25,100 $6.07 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $795,520 - $910,400	4,000 Added 400.0%	5,000 $1.13 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $187,720 - $208,760	-800 Reduced 44.44%	1,000 $254,000
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $2.47 Million - $3.03 Million	-12,500 Reduced 87.41%	1,800 $425,000
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $2.48 Million - $3.29 Million	-13,600 Reduced 48.75%	14,300 $2.9 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $5.28 Million - $6.79 Million	27,900 New	27,900 $6.72 Million
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $100,020 - $117,246	-600 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $886,263 - $999,012	-4,900 Reduced 89.09%	600 $114,000
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $1.55 Million - $1.81 Million	-8,700 Reduced 61.27%	5,500 $1.07 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $1.63 Million - $1.84 Million	8,800 Added 162.96%	14,200 $2.94 Million
Q2 2018 Aug 03, 2018	BUY	$166.05 - $186.51 $896,670 - $1.01 Million	5,400 New	5,400 $996,000

Others Institutions Holding AMGN

# of Institutions

3,119

Shares Held

407M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Account